Brandywine Global Investment Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$25.1M Buy
126,248
+21,435
+20% +$4.33M 0.17% 144
2025
Q3
$21.3M Buy
104,813
+43,165
+70% +$7.66M 0.15% 155
2025
Q2
$10.9M Sell
61,648
-33,681
-35% -$5.07M 0.08% 249
2025
Q1
$12.8M Buy
95,329
+43,648
+84% +$5.75M 0.09% 209
2024
Q4
$6.52M Sell
51,681
-3,503
-6% -$521K 0.05% 317
2024
Q3
$8.57M Buy
55,184
+2,046
+4% +$309K 0.06% 293
2024
Q2
$7.07M Buy
53,138
+10,592
+25% +$1.28M 0.05% 329
2024
Q1
$4.47M Sell
42,546
-119
-0.3% -$10.7K 0.03% 430
2023
Q4
$3.22M Sell
42,665
-2,597
-6% -$165K 0.03% 477
2023
Q3
$2.98M Sell
45,262
-2,450
-5% -$183K 0.03% 481
2023
Q2
$3.88M Buy
+47,712
New +$3.4M 0.03% 428

Other funds holding THC

Brandywine Global Investment Management's THC Position: Q4 2025 in Review

Brandywine Global Investment Management increased its Tenet Healthcare (THC) stake by 20% in Q4 2025, buying an estimated $4.33M and bringing the position to 126,248 shares worth $25.1M. The position accounts for 0.17% of the portfolio, ranked #144.

Brandywine Global Investment Management first reported a position in THC in Q2 2023 and has held it in 11 quarters since. 705 funds tracked by Wall St. Rank hold THC as of Q4 2025.

  • Brandywine Global Investment Management held 126,248 shares of Tenet Healthcare worth $25.1M as of Q4 2025.
  • Brandywine Global Investment Management bought 21,435 Tenet Healthcare shares in Q4 2025, an estimated $4.33M.
  • Tenet Healthcare made up 0.17% of Brandywine Global Investment Management's portfolio in Q4 2025, its #144 holding.
  • Brandywine Global Investment Management first reported a position in Tenet Healthcare in Q2 2023 and has held it in 11 quarters since.
  • 705 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.